Myeloproliferative neoplasms trials in Australia

In Australia 19 Also abroad 210

19 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Where
Adelaide, Clayton
Age
18 years and over
People
460 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07357727 · EU 2025-523555-66-00
Phase 3Taking people
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Where
Bedford Park, Coffs Harbour, Cudgen, Fitzroy, Garran, Heidelberg, Kogarah
Age
18 years and over
People
324 worldwide
Run by
Takeda
See details and how to joinNCT07623161 · EU 2026-525660-17-00
Phase 3Taking people
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Where
Birtinya, Blacktown, Brisbane, Cooloongup, Garran, Gosford, Kurralta Park, Liverpool, Melbourne, Perth
Age
18 years and over
People
426 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07623200 · EU 2026-525398-38-00
Phase 1Taking people
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Where
Auchenflower, Concord, East Melbourne, Nedlands, St Leonards
Age
18 years and over
People
218 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07441694 · EU 2026-525217-31-00
Phase 3Taking people
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
Where
Heidelberg, Kurralta Park, West Perth
Age
18 years and over
People
250 worldwide
Run by
Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT07429266 · EU 2025-524669-25-00
Phase 1Taking people
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Where
Adelaide, Clayton, Nedlands
Age
18 years and over
People
100 worldwide
Run by
Prelude Therapeutics Incorporated
See details and how to joinNCT07469891 · EU 2026-525484-40-00
Phase 1Taking people
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
Where
Adelaide, Brisbane, Liverpool, Melbourne, Newcastle, Perth, Sunshine Coast, Sydney
Age
18 years and over
People
250 worldwide
Run by
Damora Therapeutics
See details and how to joinNCT07849231
Phase 2Not yet taking people in Australia
Phase 2 Study of Oral Epetraborole in Adults With Polycythemia Vera
Where
Perth
Age
18 years to 75 years
People
75
Run by
AN2 Therapeutics, Inc
See details and how to joinNCT07891533
Phase 1/2Taking people
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Where
Nedlands, Saint Albans, Sydney, West Perth
Age
18 years and over
People
150 worldwide
Run by
Disc Medicine, Inc
See details and how to joinNCT05320198
Phase 1/2Taking people
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Where
Adelaide, Box Hill, Clayton, Fitzroy, Melbourne, Richmond
Age
18 years and over
People
240 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04176198 · EU 2022-502597-16-00
Phase 2Taking people
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Where
Kingswood, Melbourne N., Southport
Age
18 years and over
People
140 worldwide
Run by
Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00
Phase 1/2Taking people
A Study of BGB-11417 in Participants With Myeloid Malignancies
Where
Clayton, Concord, Fitzroy, Heidelberg, Kogarah, Melbourne, Murdoch, Nedlands, Orange, Southport
Age
18 years and over
People
260 worldwide
Run by
BeOne Medicines
See details and how to joinNCT04771130 · EU 2023-508881-14-00
No phaseTaking people
Project: Every Child for Younger Patients With Cancer
Where
Clayton, Hunter Regional Mail Centre, North Adelaide, Parkville, Perth, Randwick, Saint Hobart, South Brisbane, Westmead
Age
Up to 25 years
People
75,000 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT02402244
Phase 1Taking people
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Where
Adelaide, Melbourne, Nedlands, Sydney
Age
18 years and over
People
120 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07008118
Phase 3Taking people
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Where
Adelaide, Camperdown, Clayton, South Brisbane
Age
18 years and over
People
665 worldwide
Run by
Celgene
See details and how to joinNCT04064060
Phase 1/2Taking people
Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis
Where
Adelaide, Melbourne, Nedlands, Perth, Sydney
Age
18 years and over
People
30
Run by
Jubilant Therapeutics Inc.
See details and how to joinNCT07612280
Phase 3Taking people
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Where
Adelaide, Buderim, Camperdown, Clayton, Southport, St Leonards
Age
18 years and over
People
400 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06351631 · EU 2023-506996-89-00
Phase 2Taking people
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
Where
Concord, Fitzroy, Melbourne, Tweed Heads, Wendouree, Woodville South
Age
18 years and over
People
135 worldwide
Run by
Takeda
See details and how to joinNCT05037760 · EU 2023-507468-38-00
Phase 3Taking people
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Where
Adelaide, Clayton, Douglas, Gosford, Hobart, Kogarah, Melbourne, Nedlands, Perth, Waratah
Age
18 years and over
People
600 worldwide
Run by
Kartos Therapeutics, Inc.
See details and how to joinNCT06479135